Tinidazole
- Generic Name
- Tinidazole
- Brand Names
- Tindamax
- Drug Type
- Small Molecule
- Chemical Formula
- C8H13N3O4S
- CAS Number
- 19387-91-8
- Unique Ingredient Identifier
- 033KF7V46H
- Background
A nitroimidazole antitrichomonal agent effective against Trichomonas vaginalis, Entamoeba histolytica, and Giardia lamblia infections.
- Indication
For the treatment of trichomoniasis caused by T. vaginalis in both female and male patients. Also for the treatment of giardiasis caused by G. duodenalis in both adults and pediatric patients older than three years of age and for the treatment of intestinal amebiasis and amebic liver abscess caused by E. histolytica in both adults and pediatric patients older than three years of age.
- Associated Conditions
- Amebiasis, Bacterial Vaginosis (BV), Giardiasis, Mixed Vaginal Infections, Nongonococcal urethritis, Sexually Transmitted Disease (STD), Trichomonas Vaginalis Infection, Trichomonas Vaginitis, Vaginal Candidiasis
Pilot Human Study of Tinidazole Efficacy For Radical Cure Of Plasmodium Vivax
- First Posted Date
- 2008-12-18
- Last Posted Date
- 2012-12-03
- Lead Sponsor
- Walter Reed Army Institute of Research (WRAIR)
- Target Recruit Count
- 20
- Registration Number
- NCT00811096
- Locations
- 🇹🇭
Malaria Research Unit, 68/30 Ban Toong Road, P.O. Box 46, Mae Sot, 63110, Tak, Thailand
Tinidazole Versus Cefazolin Antibiotic Prophylaxis of Vaginal and Abdominal Hysterectomy
- Conditions
- Hysterectomy
- Interventions
- First Posted Date
- 2008-11-07
- Last Posted Date
- 2008-11-07
- Lead Sponsor
- University of Campinas, Brazil
- Target Recruit Count
- 75
- Registration Number
- NCT00787553
- Locations
- 🇧🇷
University of Campinas, Campinas, SP, Brazil
Tinidazole for Recurrent Bacterial Vaginosis: A Pilot Study
- First Posted Date
- 2007-08-02
- Last Posted Date
- 2011-02-18
- Lead Sponsor
- University of Pittsburgh
- Target Recruit Count
- 37
- Registration Number
- NCT00510614
- Locations
- 🇺🇸
Magee-Womens Hospital of UPMC, Pittsburgh, Pennsylvania, United States
A Pilot Study of Oral Tinidazole for Women With Recurrent Bacterial Vaginosis
- Conditions
- Recurrent Bacterial Vaginosis
- First Posted Date
- 2006-05-10
- Last Posted Date
- 2012-08-02
- Lead Sponsor
- Kaiser Permanente
- Registration Number
- NCT00324142
- Locations
- 🇺🇸
Kaiser Permanente, San Francisco, California, United States
NGU: Doxycycline (Plus or Minus Tinidazole) Versus Azithromycin (Plus or Minus Tinidazole)
- Conditions
- Urethritis
- Interventions
- First Posted Date
- 2006-05-08
- Last Posted Date
- 2019-03-01
- Target Recruit Count
- 305
- Registration Number
- NCT00322465
- Locations
- 🇺🇸
Delgado Personal Health Center, New Orleans, Louisiana, United States
🇺🇸University of Alabama Hospital - Infectious Diseases, Birmingham, Alabama, United States
🇺🇸University of North Carolina School of Medicine - Center for Infectious Diseases, Chapel Hill, North Carolina, United States
Treatment of Bacterial Vaginosis With Oral Tinidazole
- Conditions
- Bacterial Vaginosis
- First Posted Date
- 2005-09-29
- Last Posted Date
- 2017-03-22
- Lead Sponsor
- Mission Pharmacal
- Target Recruit Count
- 200
- Registration Number
- NCT00229216
- Locations
- 🇺🇸
Duke University School of Medicine, Durham, North Carolina, United States
Chlorambucil Compared With No Further Therapy Following Anti-Helicobacter Therapy in Treating Patients With Low-Grade Lymphoma of the Stomach
- Conditions
- Gastric Cancer
- First Posted Date
- 2004-03-12
- Last Posted Date
- 2013-09-20
- Lead Sponsor
- Lymphoma Trials Office
- Target Recruit Count
- 200
- Registration Number
- NCT00003617
- Locations
- 🇬🇧
Clatterbridge Centre for Oncology NHS Trust, Merseyside, England, United Kingdom
🇬🇧Leeds Teaching Hospital Trust, Leeds, England, United Kingdom
🇬🇧Essex County Hospital, Colchester, England, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.